Name: Latest research reports of Corona Remedies Ltd. authored by HDFC Securities and published by - Trendlyne research reports.
Item: Corona Remedies Ltd.
Rating: 3
Author: HDFC Securities

Corona Remedies Ltd.

NSE: CORONA | BSE: 544644 | ISIN: INE02ZQ01018 | Industry: Pharmaceuticals
|

1430.1000 -32.90 (-2.25%)

NSE Jan 09, 2026 15:31 PM

Volume: 82,838

Corona Remedies Ltd.

08 Dec 2025, 09:53AM

1430.10

-2.25%

IPO Note - Corona Remedies Limited - 08122025

IPO Note: Corona Remedies Ltd.

HDFC Securities

IPO Note - Corona Remedies Limited Corona Remedies Limited is an India-focused branded pharma firm, develops, manufactures, and markets 71 brands across women's healthcare, cardio-diabeto, pain management, urology, and more

Corona Remedies has gained 34.66% in the last 1 Month